HEADER HYDROLASE 07-DEC-17 6BTO TITLE BMP1 COMPLEXED WITH (2~{S})-2-[[(1~{R},3~{S},4~{S})-2-[(2~{R})-2-[2- TITLE 2 (OXIDANYLAMINO)-2-OXIDANYLIDENE-ETHYL]HEPTANOYL]-2- TITLE 3 AZABICYCLO[2.2.1]HEPTAN-3-YL]CARBONYLAMINO]-2-PHENYL-ETHANOIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: BONE MORPHOGENETIC PROTEIN 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 121-321; COMPND 5 SYNONYM: BMP-1,MAMMALIAN TOLLOID PROTEIN,MTLD,PROCOLLAGEN C- COMPND 6 PROTEINASE,PCP; COMPND 7 EC: 3.4.24.19; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BMP1, PCOLC; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ENDOPEPTIDASE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR R.GAMPE,L.SHEWCHUK REVDAT 2 24-APR-19 6BTO 1 TITLE REVDAT 1 08-AUG-18 6BTO 0 JRNL AUTH L.S.KALLANDER,D.WASHBURN,M.A.HILFIKER,H.S.EIDAM,B.G.LAWHORN, JRNL AUTH 2 J.PRENDERGAST,R.FOX,S.DOWDELL,S.MANNS,T.HOANG,S.ZHAO,G.YE, JRNL AUTH 3 M.HAMMOND,D.A.HOLT,T.ROETHKE,X.HONG,R.A.REID,R.GAMPE, JRNL AUTH 4 H.ZHANG,E.DIAZ,A.R.RENDINA,A.M.QUINN,B.WILLETTE JRNL TITL REVERSE HYDROXAMATE INHIBITORS OF BONE MORPHOGENETIC PROTEIN JRNL TITL 2 1. JRNL REF ACS MED CHEM LETT V. 9 736 2018 JRNL REFN ISSN 1948-5875 JRNL PMID 30034610 JRNL DOI 10.1021/ACSMEDCHEMLETT.8B00173 REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 29975 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1593 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.06 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.11 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2155 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.39 REMARK 3 BIN R VALUE (WORKING SET) : 0.2120 REMARK 3 BIN FREE R VALUE SET COUNT : 131 REMARK 3 BIN FREE R VALUE : 0.2500 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3183 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 333 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : -0.04000 REMARK 3 B33 (A**2) : -0.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.208 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.177 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.125 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.277 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.888 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3346 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2965 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4540 ; 1.263 ; 1.925 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6852 ; 0.942 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 407 ; 5.982 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 169 ;29.182 ;22.308 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 517 ;12.843 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 35 ;16.438 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 467 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3781 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 768 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 201 REMARK 3 ORIGIN FOR THE GROUP (A): 16.1370 16.6900 0.0830 REMARK 3 T TENSOR REMARK 3 T11: 0.0628 T22: 0.0878 REMARK 3 T33: 0.1366 T12: 0.0047 REMARK 3 T13: 0.0255 T23: -0.0178 REMARK 3 L TENSOR REMARK 3 L11: 1.3947 L22: 4.9804 REMARK 3 L33: 0.8294 L12: -0.4241 REMARK 3 L13: 0.2571 L23: -0.3594 REMARK 3 S TENSOR REMARK 3 S11: -0.0381 S12: 0.0507 S13: 0.2275 REMARK 3 S21: -0.2482 S22: -0.0160 S23: -0.7173 REMARK 3 S31: -0.0570 S32: 0.0725 S33: 0.0541 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 200 REMARK 3 ORIGIN FOR THE GROUP (A): -15.4920 9.9490 -7.3040 REMARK 3 T TENSOR REMARK 3 T11: 0.0335 T22: 0.0418 REMARK 3 T33: 0.0111 T12: -0.0165 REMARK 3 T13: -0.0135 T23: 0.0096 REMARK 3 L TENSOR REMARK 3 L11: 1.2632 L22: 0.8177 REMARK 3 L33: 0.9936 L12: -0.3523 REMARK 3 L13: -0.5029 L23: 0.4278 REMARK 3 S TENSOR REMARK 3 S11: 0.0392 S12: 0.0505 S13: 0.0191 REMARK 3 S21: -0.0400 S22: -0.0050 S23: -0.0142 REMARK 3 S31: -0.0791 S32: 0.0382 S33: -0.0341 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 6BTO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-DEC-17. REMARK 100 THE DEPOSITION ID IS D_1000231353. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN A200 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31641 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 124.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.44600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8-12% PEG 3350 150-200MM KSCN 10MM REMARK 280 SPERMIDINE, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 45.14550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.88800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 62.32150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 21.88800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 45.14550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 62.32150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 MET B 0 REMARK 465 ALA B 201 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 5 NE CZ NH1 NH2 REMARK 470 LYS A 83 CG CD CE NZ REMARK 470 LYS A 87 CD CE NZ REMARK 470 ARG A 112 CZ NH1 NH2 REMARK 470 GLU A 138 CG CD OE1 OE2 REMARK 470 SER A 139 OG REMARK 470 ASN A 173 CG OD1 ND2 REMARK 470 VAL A 175 CG1 CG2 REMARK 470 LYS A 176 CG CD CE NZ REMARK 470 LYS A 187 CD CE NZ REMARK 470 LYS B 40 CE NZ REMARK 470 LYS B 83 CG CD CE NZ REMARK 470 LYS B 176 CG CD CE NZ REMARK 470 LYS B 187 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 28 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 28 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 12 14.49 58.72 REMARK 500 THR A 50 -78.66 -103.02 REMARK 500 ARG A 61 148.62 -172.44 REMARK 500 CYS A 85 40.49 -146.08 REMARK 500 THR B 50 -74.51 -120.36 REMARK 500 CYS B 85 49.05 -153.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 CYS B 65 CYS B 66 -149.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 539 DISTANCE = 5.85 ANGSTROMS REMARK 525 HOH B 593 DISTANCE = 6.03 ANGSTROMS REMARK 525 HOH B 594 DISTANCE = 7.60 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 93 NE2 REMARK 620 2 HIS A 97 NE2 96.4 REMARK 620 3 HIS A 103 NE2 104.0 103.2 REMARK 620 4 E8P A 304 O23 163.0 95.0 85.4 REMARK 620 5 E8P A 304 O26 98.4 86.8 154.2 69.8 REMARK 620 6 HOH A 471 O 88.6 164.6 89.6 77.3 78.1 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 93 NE2 REMARK 620 2 HIS B 97 NE2 100.7 REMARK 620 3 HIS B 103 NE2 111.9 99.8 REMARK 620 4 HOH B 532 O 115.1 101.9 122.6 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SCN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E8P A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SCN B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZN B 302 DBREF 6BTO A 1 201 UNP P13497 BMP1_HUMAN 121 321 DBREF 6BTO B 1 201 UNP P13497 BMP1_HUMAN 121 321 SEQADV 6BTO MET A 0 UNP P13497 INITIATING METHIONINE SEQADV 6BTO MET B 0 UNP P13497 INITIATING METHIONINE SEQRES 1 A 202 MET ALA ALA THR SER ARG PRO GLU ARG VAL TRP PRO ASP SEQRES 2 A 202 GLY VAL ILE PRO PHE VAL ILE GLY GLY ASN PHE THR GLY SEQRES 3 A 202 SER GLN ARG ALA VAL PHE ARG GLN ALA MET ARG HIS TRP SEQRES 4 A 202 GLU LYS HIS THR CYS VAL THR PHE LEU GLU ARG THR ASP SEQRES 5 A 202 GLU ASP SER TYR ILE VAL PHE THR TYR ARG PRO CYS GLY SEQRES 6 A 202 CYS CYS SER TYR VAL GLY ARG ARG GLY GLY GLY PRO GLN SEQRES 7 A 202 ALA ILE SER ILE GLY LYS ASN CYS ASP LYS PHE GLY ILE SEQRES 8 A 202 VAL VAL HIS GLU LEU GLY HIS VAL VAL GLY PHE TRP HIS SEQRES 9 A 202 GLU HIS THR ARG PRO ASP ARG ASP ARG HIS VAL SER ILE SEQRES 10 A 202 VAL ARG GLU ASN ILE GLN PRO GLY GLN GLU TYR ASN PHE SEQRES 11 A 202 LEU LYS MET GLU PRO GLN GLU VAL GLU SER LEU GLY GLU SEQRES 12 A 202 THR TYR ASP PHE ASP SER ILE MET HIS TYR ALA ARG ASN SEQRES 13 A 202 THR PHE SER ARG GLY ILE PHE LEU ASP THR ILE VAL PRO SEQRES 14 A 202 LYS TYR GLU VAL ASN GLY VAL LYS PRO PRO ILE GLY GLN SEQRES 15 A 202 ARG THR ARG LEU SER LYS GLY ASP ILE ALA GLN ALA ARG SEQRES 16 A 202 LYS LEU TYR LYS CYS PRO ALA SEQRES 1 B 202 MET ALA ALA THR SER ARG PRO GLU ARG VAL TRP PRO ASP SEQRES 2 B 202 GLY VAL ILE PRO PHE VAL ILE GLY GLY ASN PHE THR GLY SEQRES 3 B 202 SER GLN ARG ALA VAL PHE ARG GLN ALA MET ARG HIS TRP SEQRES 4 B 202 GLU LYS HIS THR CYS VAL THR PHE LEU GLU ARG THR ASP SEQRES 5 B 202 GLU ASP SER TYR ILE VAL PHE THR TYR ARG PRO CYS GLY SEQRES 6 B 202 CYS CYS SER TYR VAL GLY ARG ARG GLY GLY GLY PRO GLN SEQRES 7 B 202 ALA ILE SER ILE GLY LYS ASN CYS ASP LYS PHE GLY ILE SEQRES 8 B 202 VAL VAL HIS GLU LEU GLY HIS VAL VAL GLY PHE TRP HIS SEQRES 9 B 202 GLU HIS THR ARG PRO ASP ARG ASP ARG HIS VAL SER ILE SEQRES 10 B 202 VAL ARG GLU ASN ILE GLN PRO GLY GLN GLU TYR ASN PHE SEQRES 11 B 202 LEU LYS MET GLU PRO GLN GLU VAL GLU SER LEU GLY GLU SEQRES 12 B 202 THR TYR ASP PHE ASP SER ILE MET HIS TYR ALA ARG ASN SEQRES 13 B 202 THR PHE SER ARG GLY ILE PHE LEU ASP THR ILE VAL PRO SEQRES 14 B 202 LYS TYR GLU VAL ASN GLY VAL LYS PRO PRO ILE GLY GLN SEQRES 15 B 202 ARG THR ARG LEU SER LYS GLY ASP ILE ALA GLN ALA ARG SEQRES 16 B 202 LYS LEU TYR LYS CYS PRO ALA HET SCN A 301 3 HET ZN A 302 1 HET ZN A 303 1 HET E8P A 304 33 HET EDO A 305 4 HET SCN B 301 3 HET ZN B 302 1 HETNAM SCN THIOCYANATE ION HETNAM ZN ZINC ION HETNAM E8P (2~{S})-2-[[(1~{R},3~{S},4~{S})-2-[(2~{R})-2-[2- HETNAM 2 E8P (OXIDANYLAMINO)-2-OXIDANYLIDENE-ETHYL]HEPTANOYL]-2- HETNAM 3 E8P AZABICYCLO[2.2.1]HEPTAN-3-YL]CARBONYLAMINO]-2-PHENYL- HETNAM 4 E8P ETHANOIC ACID HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 SCN 2(C N S 1-) FORMUL 4 ZN 3(ZN 2+) FORMUL 6 E8P C24 H33 N3 O6 FORMUL 7 EDO C2 H6 O2 FORMUL 10 HOH *333(H2 O) HELIX 1 AA1 ARG A 5 VAL A 9 5 5 HELIX 2 AA2 TRP A 10 ASP A 12 5 3 HELIX 3 AA3 THR A 24 THR A 42 1 19 HELIX 4 AA4 GLY A 82 ASP A 86 5 5 HELIX 5 AA5 LYS A 87 GLY A 100 1 14 HELIX 6 AA6 HIS A 103 ARG A 107 5 5 HELIX 7 AA7 ASP A 109 ARG A 112 5 4 HELIX 8 AA8 ARG A 118 ILE A 121 5 4 HELIX 9 AA9 GLN A 125 LEU A 130 5 6 HELIX 10 AB1 GLU A 133 GLN A 135 5 3 HELIX 11 AB2 SER A 186 TYR A 197 1 12 HELIX 12 AB3 ARG B 5 VAL B 9 5 5 HELIX 13 AB4 TRP B 10 ASP B 12 5 3 HELIX 14 AB5 THR B 24 THR B 42 1 19 HELIX 15 AB6 LYS B 87 GLY B 100 1 14 HELIX 16 AB7 HIS B 103 ARG B 107 5 5 HELIX 17 AB8 ASP B 109 ARG B 112 5 4 HELIX 18 AB9 ARG B 118 ILE B 121 5 4 HELIX 19 AC1 GLN B 125 LEU B 130 5 6 HELIX 20 AC2 GLU B 133 VAL B 137 5 5 HELIX 21 AC3 SER B 186 TYR B 197 1 12 SHEET 1 AA1 2 ALA A 2 THR A 3 0 SHEET 2 AA1 2 VAL A 137 GLU A 138 -1 O GLU A 138 N ALA A 2 SHEET 1 AA2 4 THR A 45 GLU A 48 0 SHEET 2 AA2 4 VAL A 14 ILE A 19 1 N ILE A 15 O THR A 45 SHEET 3 AA2 4 TYR A 55 TYR A 60 1 O PHE A 58 N VAL A 18 SHEET 4 AA2 4 PRO A 76 ILE A 81 1 O ILE A 79 N THR A 59 SHEET 1 AA3 2 VAL A 114 ILE A 116 0 SHEET 2 AA3 2 ILE A 166 PRO A 168 -1 O VAL A 167 N SER A 115 SHEET 1 AA4 4 THR B 45 GLU B 48 0 SHEET 2 AA4 4 VAL B 14 ILE B 19 1 N ILE B 15 O THR B 45 SHEET 3 AA4 4 TYR B 55 TYR B 60 1 O ILE B 56 N PRO B 16 SHEET 4 AA4 4 PRO B 76 ILE B 81 1 O ILE B 81 N THR B 59 SHEET 1 AA5 2 VAL B 114 ILE B 116 0 SHEET 2 AA5 2 ILE B 166 PRO B 168 -1 O VAL B 167 N SER B 115 SSBOND 1 CYS A 43 CYS A 199 1555 1555 2.03 SSBOND 2 CYS A 63 CYS A 85 1555 1555 2.03 SSBOND 3 CYS A 65 CYS A 66 1555 1555 2.04 SSBOND 4 CYS B 43 CYS B 199 1555 1555 2.04 SSBOND 5 CYS B 63 CYS B 85 1555 1555 2.03 SSBOND 6 CYS B 65 CYS B 66 1555 1555 2.06 LINK NE2 HIS A 93 ZN ZN A 302 1555 1555 2.16 LINK NE2 HIS A 97 ZN ZN A 302 1555 1555 2.13 LINK NE2 HIS A 103 ZN ZN A 302 1555 1555 2.17 LINK NE2 HIS B 93 ZN ZN B 302 1555 1555 2.02 LINK NE2 HIS B 97 ZN ZN B 302 1555 1555 2.09 LINK NE2 HIS B 103 ZN ZN B 302 1555 1555 2.02 LINK ZN ZN A 302 O23 E8P A 304 1555 1555 2.26 LINK ZN ZN A 302 O26 E8P A 304 1555 1555 2.39 LINK ZN ZN A 302 O HOH A 471 1555 1555 2.36 LINK ZN ZN B 302 O HOH B 532 1555 1555 1.94 CISPEP 1 CYS A 65 CYS A 66 0 -3.13 SITE 1 AC1 4 ARG A 110 ILE A 116 HOH A 447 PHE B 162 SITE 1 AC2 5 HIS A 93 HIS A 97 HIS A 103 E8P A 304 SITE 2 AC2 5 HOH A 471 SITE 1 AC3 4 ASP A 145 SER A 148 GLY A 188 ASP A 189 SITE 1 AC4 15 ARG A 8 CYS A 66 SER A 67 TYR A 68 SITE 2 AC4 15 VAL A 69 HIS A 93 GLU A 94 HIS A 97 SITE 3 AC4 15 TRP A 102 HIS A 103 GLN A 125 TYR A 127 SITE 4 AC4 15 ZN A 302 HOH A 413 HOH A 471 SITE 1 AC5 5 ARG A 32 MET A 35 GLU A 39 HOH A 420 SITE 2 AC5 5 HOH A 472 SITE 1 AC6 5 THR B 24 PRO B 108 ASP B 109 VAL B 137 SITE 2 AC6 5 HOH B 522 SITE 1 AC7 4 HIS B 93 HIS B 97 HIS B 103 HOH B 532 CRYST1 90.291 124.643 43.776 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011075 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008023 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022844 0.00000